It has been found in in vitro studies that phytoestrogens, like estrogens, bind to estrogen receptors and increase the synthesis of SHBG by liver cells, but, like anti-estrogens, they inhibit aromatase activity and breast cancer cell proliferation. Here, ESR1 is linked to breast carcinoma.